No Data
No Data
Guggenheim Maintains Scynexis(SCYX.US) With Buy Rating, Cuts Target Price to $5
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Express News | Scynexis Inc : Guggenheim Cuts Target Price to $5 From $6
SCYNEXIS Full Year 2024 Earnings: Misses Expectations
Maxim Group Maintains Scynexis(SCYX.US) With Buy Rating, Cuts Target Price to $4
loading...